SEC Form 5 · accession 0001093557-19-000031
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven R Altman
Director
Period of report
Dec 31, 2018
Accepted (ET)
Feb 15, 2019 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2018 | J | 4,353 | $0.00 | D | 3,449 | D | |
| Common StockF2 | Aug 24, 2018 | J | 5,000 | $0.00 | A | 5,000 | I | By Foundation |
| Common StockF1 | Jun 1, 2018 | J | 4,353 | $0.00 | A | 62,855 | I | by Trust |
| Common StockF2 | Aug 24, 2018 | J | 5,000 | $0.00 | D | 57,855 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were transferred from direct ownership to ownership under the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, upon vesting of previously awarded restricted stock units.
- F2Shares were transferred from the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, to ownership under The Lisa and Steve Altman Family Foundation with respect to which the reporting person is an authorized agent.